← All indications
Fatigue
The state of weariness following a period of exertion, mental or physical, characterized by a decreased capacity for work and reduced efficiency to respond to stimuli.
Subtype terms (3)
More specific conditions that are subtypes of Fatigue in the MeSH hierarchy.
- Emotional Exhaustion
- Mental Fatigue
12 drugs (3 approved, 9 experimental)
- Overtraining Syndrome
Drugs by status
Approved for this indication (8)
Phase 4 trials (29)
- propofol
- vitamin d3
- methylprednisolone
- acetylcarnitine
- epoetin
- astragalus membranaceus
- cyclobenzaprine
- prednisone
- suvorexant
- droxidopa
- ferric carboxymaltose
- ginseng
- amantadine
- ursodeoxycholic acid
- myoinositol
- riluzole
- desflurane
- taurine
- thiamine
- bupropion
- midazolam
- modafinil
- levothyroxine
- riboflavin
- sodium chloride
- amphetamine
- armodafinil
- ferrous sulfate
- fisetin
Phase 3 trials (24)
Phase 2 trials (39)
- maltodextrin
- dalfampridine
- acetylcysteine
- lenalidomide
- ketamine
- clazakizumab
- disulfiram
- cannabidiol
- obinutuzumab
- gemcitabine
- icosapent ethyl
- fluoxetine
- megestrol
- regorafenib
- ofatumumab
- donepezil
- reparixin
- tetrahydrocannabinol
- testosterone
- Veverimer
- vinorelbine
- xylitol
- mitoquinone
- tw1025
- rituximab
- cisplatin
- sodium bicarbonate
- amifampridine phosphate
- tenofovir alafenamide
- anakinra
- +9 more
Phase 1 trials (4)
Other trials (59)
- vitamin e
- calcium carbonate
- bu-zhong-yi-qi-tang
- caffeic acid
- tadalafil
- cocoa bean
- d-ribose
- doxycycline
- doxorubicin
- palmitoylethanolamide
- ritonavir
- Epimedium
- whey protein
- iron sucrose
- kefir
- oxaloacetate
- cow milk
- adalimumab
- trastuzumab
- caffeine
- sunitinib
- red blood cells
- sitagliptin
- cyclophosphamide
- beractant
- cholesterol
- cellulose
- bifidobacterium longum
- citrus flavonoid
- coffee
- +29 more
Organizations
Organization Involved with Phase 4 Indications (84)
- Pierre Fabre
- Jazz Pharmaceuticals
- Cephalon
- Shire
- Forest Laboratories
- Merck
- Pfizer
- Sanofi
- Biogen
- Ampel BioSolutions, LLC
- Bayer
- Dong-A Pharmaceutical
- Laboratorios Viñas, S.A.
- PhytoHealth Corporation
- Teva
- Vifor Inc.
- Boehringer Ingelheim
- Daewoong Pharmaceutical Co. LTD.
- ZonMw: The Netherlands Organisation for Health Research and Development
- Medical Research Council
- National Cancer Institute (NCI)
- National Institute of Mental Health (NIMH)
- Aarhus University
- University of Pittsburgh
- University of London
- Cornell University
- Cornerstone Health Care, PA
- Harvard University
- Duke University
- Federal University of Juiz de Fora
- +54 more
Organization Involved with Phase 3 Indications (88)
- Symyoo
- Green Cross Corporation
- McNeil
- BioCryst
- Hemispherx Biopharma
- Eli Lilly
- Biolab Sanus Farmaceutica
- Mallinckrodt
- Medice Arzneimittel Pütter GmbH & Co KG
- Oncotherapeutics
- Bionov
- National Institute of Neurological Disorders and Stroke (NINDS)
- National Institute of Nursing Research (NINR)
- Ajou University
- Cancer and Leukemia Group B (CALGB)
- Cancer Research Network
- Chang Gung University
- Changhua Christian Hospital
- Danish Cancer Society
- Eastern Cooperative Oncology Group
- ECOG-ACRIN Cancer Research Group
- Gynecologic Oncology Group
- Indira Gandhi Medical College
- Instituto Mexicano del Seguro Social
- International Breast Cancer Study Group
- Kaohsiung Medical University
- Johns Hopkins University
- National Cheng Kung University
- NRG Oncology
- New York University
- +58 more
Organization Involved with Phase 2 Indications (84)
- Incyte
- Chelsea Therapeutics
- Acorda Therapeutics
- Celgene
- Genentech
- Helsinn
- Indena S.p.A
- Leadiant Biosciences, Inc.
- Meriyana Bio Inc.
- Ortho Biotech, Inc.
- PharmaLundensis AB
- Kessler Foundation
- Research Foundation for Mental Hygiene, Inc.
- Center for Health, Exercise and Sport Sciences, Serbia
- Government of Alberta
- National Center for Complementary and Integrative Health (NCCIH)
- National Institute of Allergy and Infectious Diseases (NIAID)
- University of Pennsylvania
- University of Arizona
- University of Manitoba
- Arizona Oncology Services
- Baylor University
- Clinical Research Support Center Kyush
- Dartmouth University
- Faculdade de Medicina do ABC
- Kumamoto University
- Newcastle University
- Northwestern University
- Oregon Health and Science University
- University of Nottingham
- +54 more
Organization Involved with Phase 1 Indications (14)
- Ajinomoto
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Craig Hospital
- McMaster University
- Medical College of Wisconsin
- University of Miami
- University of Utah
- Vanderbilt University
- University of Basel
- University of Missouri
- University of Alabama, Birmingham
- American College of Gastroenterology
- The University of Texas, Dallas
- Band of Hope Foundation
Organization Involved with Other Experimental Indications (61)
- Abbott
- Bioenergy Life Science, Inc.
- Enovate Biolife Pvt Ltd
- Immunotec Inc.
- InQpharm Group
- Korea Ginseng Corporation
- Livzon Pharmaceutical Group Inc.
- Vedic Lifesciences Pvt. Ltd.
- Vital Solutions
- NBTY, Inc.
- Maastricht University
- Brock University
- Case Western Reserve University
- Catholic Kwandong University
- Chung Shan Medical University
- China Academy of Chinese Medical Sciences
- Federal University of Health Science of Porto Alegre
- Hanyang University
- Inje University
- Kyung Hee University
- Ohio State University
- Oxford Brookes University
- The Korean Society of Ginseng
- University of East Anglia
- University of Exeter
- University of Kentucky
- University of Mary Hardin-Baylor
- University of Nove de Julho
- University of Vermont
- University of Virginia
- +31 more